HEADER ONCOPROTEIN 18-MAY-23 8SWE TITLE FGFR2 KINASE DOMAIN BOUND TO REVERSIBLE INHIBITOR CMPD 3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FGFR-2,K-SAM,KGFR,KERATINOCYTE GROWTH FACTOR RECEPTOR; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR2, BEK, KGFR, KSAM; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR KINASE, ONCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.VALVERDE,L.FOSTER REVDAT 1 14-FEB-24 8SWE 0 JRNL AUTH H.SCHONHERR,P.AYAZ,A.M.TAYLOR,J.B.CASALETTO,B.B.TOURE, JRNL AUTH 2 D.T.MOUSTAKAS,B.M.HUDSON,R.VALVERDE,S.ZHAO,P.J.O'HEARN, JRNL AUTH 3 L.FOSTER,D.A.SHARON,S.GARFINKLE,F.GIORDANETTO,A.LESCARBEAU, JRNL AUTH 4 R.KURUKULASURIYA,N.GERAMI-MOAYED,D.MAGLIC,K.BRUDEREK,G.NAIK, JRNL AUTH 5 H.GUNAYDIN,M.M.MADER,A.A.BOEZIO,T.H.MCLEAN,R.CHEN,Y.WANG, JRNL AUTH 6 D.E.SHAW,J.WATTERS,D.A.BERGSTROM JRNL TITL DISCOVERY OF LIRAFUGRATINIB (RLY-4008), A HIGHLY SELECTIVE JRNL TITL 2 IRREVERSIBLE SMALL-MOLECULE INHIBITOR OF FGFR2. JRNL REF PROC.NATL.ACAD.SCI.USA V. 121 56121 2024 JRNL REFN ESSN 1091-6490 JRNL PMID 38300868 JRNL DOI 10.1073/PNAS.2317756121 REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 78.37 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 38979 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1173 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 78.3700 - 4.4800 1.00 5022 156 0.1821 0.2039 REMARK 3 2 4.4800 - 3.5600 1.00 4815 150 0.1694 0.2155 REMARK 3 3 3.5600 - 3.1100 1.00 4761 147 0.1965 0.2288 REMARK 3 4 3.1100 - 2.8200 1.00 4746 148 0.2405 0.2799 REMARK 3 5 2.8200 - 2.6200 1.00 4736 147 0.2333 0.3126 REMARK 3 6 2.6200 - 2.4700 1.00 4725 147 0.2604 0.3276 REMARK 3 7 2.4700 - 2.3400 1.00 4687 145 0.2998 0.3427 REMARK 3 8 2.3400 - 2.2400 0.92 4314 133 0.4017 0.4208 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.332 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.337 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.85 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4790 REMARK 3 ANGLE : 0.716 6468 REMARK 3 CHIRALITY : 0.045 698 REMARK 3 PLANARITY : 0.005 823 REMARK 3 DIHEDRAL : 11.542 658 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8SWE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAY-23. REMARK 100 THE DEPOSITION ID IS D_1000274373. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-AUG-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7-8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.11584 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38979 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.230 REMARK 200 RESOLUTION RANGE LOW (A) : 78.370 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.23 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.250 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3RI1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 27 % PEG 4000, 0.1 M HEPES PH7.5, REMARK 280 0.252 M AMMONIUM SULFATE, 0.05 M GSH GSSG, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 52.73000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.56500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 52.73000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.56500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 453 REMARK 465 HIS A 454 REMARK 465 MET A 455 REMARK 465 GLY A 456 REMARK 465 SER A 457 REMARK 465 PRO A 458 REMARK 465 MET A 459 REMARK 465 LEU A 460 REMARK 465 ALA A 461 REMARK 465 GLY A 462 REMARK 465 VAL A 463 REMARK 465 SER A 464 REMARK 465 GLU A 465 REMARK 465 TYR A 466 REMARK 465 GLU A 467 REMARK 465 PRO A 582 REMARK 465 GLY A 583 REMARK 465 MET A 584 REMARK 465 GLU A 585 REMARK 465 TYR A 586 REMARK 465 SER A 587 REMARK 465 TYR A 588 REMARK 465 ASP A 589 REMARK 465 ILE A 590 REMARK 465 ASN A 591 REMARK 465 ARG A 592 REMARK 465 VAL A 593 REMARK 465 PRO A 594 REMARK 465 GLU A 595 REMARK 465 ASN A 766 REMARK 465 GLU A 767 REMARK 465 GLU A 768 REMARK 465 SER B 453 REMARK 465 HIS B 454 REMARK 465 MET B 455 REMARK 465 GLY B 456 REMARK 465 SER B 457 REMARK 465 PRO B 458 REMARK 465 MET B 459 REMARK 465 LEU B 460 REMARK 465 ALA B 461 REMARK 465 GLY B 462 REMARK 465 VAL B 463 REMARK 465 SER B 464 REMARK 465 GLU B 465 REMARK 465 TYR B 466 REMARK 465 GLU B 467 REMARK 465 GLY B 583 REMARK 465 MET B 584 REMARK 465 GLU B 585 REMARK 465 TYR B 586 REMARK 465 SER B 587 REMARK 465 TYR B 588 REMARK 465 ASP B 589 REMARK 465 ILE B 590 REMARK 465 ASN B 591 REMARK 465 ARG B 592 REMARK 465 VAL B 593 REMARK 465 PRO B 594 REMARK 465 GLU B 768 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 625 -5.74 72.49 REMARK 500 ASN A 653 58.43 -97.18 REMARK 500 CYS B 491 -44.69 -137.96 REMARK 500 ARG B 625 -7.67 77.20 REMARK 500 ASN B 653 54.66 -95.24 REMARK 500 TYR B 657 -3.45 76.59 REMARK 500 REMARK 500 REMARK: NULL DBREF 8SWE A 458 768 UNP P21802 FGFR2_HUMAN 458 768 DBREF 8SWE B 458 768 UNP P21802 FGFR2_HUMAN 458 768 SEQADV 8SWE SER A 453 UNP P21802 EXPRESSION TAG SEQADV 8SWE HIS A 454 UNP P21802 EXPRESSION TAG SEQADV 8SWE MET A 455 UNP P21802 EXPRESSION TAG SEQADV 8SWE GLY A 456 UNP P21802 EXPRESSION TAG SEQADV 8SWE SER A 457 UNP P21802 EXPRESSION TAG SEQADV 8SWE SER B 453 UNP P21802 EXPRESSION TAG SEQADV 8SWE HIS B 454 UNP P21802 EXPRESSION TAG SEQADV 8SWE MET B 455 UNP P21802 EXPRESSION TAG SEQADV 8SWE GLY B 456 UNP P21802 EXPRESSION TAG SEQADV 8SWE SER B 457 UNP P21802 EXPRESSION TAG SEQRES 1 A 316 SER HIS MET GLY SER PRO MET LEU ALA GLY VAL SER GLU SEQRES 2 A 316 TYR GLU LEU PRO GLU ASP PRO LYS TRP GLU PHE PRO ARG SEQRES 3 A 316 ASP LYS LEU THR LEU GLY LYS PRO LEU GLY GLU GLY CYS SEQRES 4 A 316 PHE GLY GLN VAL VAL MET ALA GLU ALA VAL GLY ILE ASP SEQRES 5 A 316 LYS ASP LYS PRO LYS GLU ALA VAL THR VAL ALA VAL LYS SEQRES 6 A 316 MET LEU LYS ASP ASP ALA THR GLU LYS ASP LEU SER ASP SEQRES 7 A 316 LEU VAL SER GLU MET GLU MET MET LYS MET ILE GLY LYS SEQRES 8 A 316 HIS LYS ASN ILE ILE ASN LEU LEU GLY ALA CYS THR GLN SEQRES 9 A 316 ASP GLY PRO LEU TYR VAL ILE VAL GLU TYR ALA SER LYS SEQRES 10 A 316 GLY ASN LEU ARG GLU TYR LEU ARG ALA ARG ARG PRO PRO SEQRES 11 A 316 GLY MET GLU TYR SER TYR ASP ILE ASN ARG VAL PRO GLU SEQRES 12 A 316 GLU GLN MET THR PHE LYS ASP LEU VAL SER CYS THR TYR SEQRES 13 A 316 GLN LEU ALA ARG GLY MET GLU TYR LEU ALA SER GLN LYS SEQRES 14 A 316 CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL SEQRES 15 A 316 THR GLU ASN ASN VAL MET LYS ILE ALA ASP PHE GLY LEU SEQRES 16 A 316 ALA ARG ASP ILE ASN ASN ILE ASP TYR TYR LYS LYS THR SEQRES 17 A 316 THR ASN GLY ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SEQRES 18 A 316 ALA LEU PHE ASP ARG VAL TYR THR HIS GLN SER ASP VAL SEQRES 19 A 316 TRP SER PHE GLY VAL LEU MET TRP GLU ILE PHE THR LEU SEQRES 20 A 316 GLY GLY SER PRO TYR PRO GLY ILE PRO VAL GLU GLU LEU SEQRES 21 A 316 PHE LYS LEU LEU LYS GLU GLY HIS ARG MET ASP LYS PRO SEQRES 22 A 316 ALA ASN CYS THR ASN GLU LEU TYR MET MET MET ARG ASP SEQRES 23 A 316 CYS TRP HIS ALA VAL PRO SER GLN ARG PRO THR PHE LYS SEQRES 24 A 316 GLN LEU VAL GLU ASP LEU ASP ARG ILE LEU THR LEU THR SEQRES 25 A 316 THR ASN GLU GLU SEQRES 1 B 316 SER HIS MET GLY SER PRO MET LEU ALA GLY VAL SER GLU SEQRES 2 B 316 TYR GLU LEU PRO GLU ASP PRO LYS TRP GLU PHE PRO ARG SEQRES 3 B 316 ASP LYS LEU THR LEU GLY LYS PRO LEU GLY GLU GLY CYS SEQRES 4 B 316 PHE GLY GLN VAL VAL MET ALA GLU ALA VAL GLY ILE ASP SEQRES 5 B 316 LYS ASP LYS PRO LYS GLU ALA VAL THR VAL ALA VAL LYS SEQRES 6 B 316 MET LEU LYS ASP ASP ALA THR GLU LYS ASP LEU SER ASP SEQRES 7 B 316 LEU VAL SER GLU MET GLU MET MET LYS MET ILE GLY LYS SEQRES 8 B 316 HIS LYS ASN ILE ILE ASN LEU LEU GLY ALA CYS THR GLN SEQRES 9 B 316 ASP GLY PRO LEU TYR VAL ILE VAL GLU TYR ALA SER LYS SEQRES 10 B 316 GLY ASN LEU ARG GLU TYR LEU ARG ALA ARG ARG PRO PRO SEQRES 11 B 316 GLY MET GLU TYR SER TYR ASP ILE ASN ARG VAL PRO GLU SEQRES 12 B 316 GLU GLN MET THR PHE LYS ASP LEU VAL SER CYS THR TYR SEQRES 13 B 316 GLN LEU ALA ARG GLY MET GLU TYR LEU ALA SER GLN LYS SEQRES 14 B 316 CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL SEQRES 15 B 316 THR GLU ASN ASN VAL MET LYS ILE ALA ASP PHE GLY LEU SEQRES 16 B 316 ALA ARG ASP ILE ASN ASN ILE ASP TYR TYR LYS LYS THR SEQRES 17 B 316 THR ASN GLY ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SEQRES 18 B 316 ALA LEU PHE ASP ARG VAL TYR THR HIS GLN SER ASP VAL SEQRES 19 B 316 TRP SER PHE GLY VAL LEU MET TRP GLU ILE PHE THR LEU SEQRES 20 B 316 GLY GLY SER PRO TYR PRO GLY ILE PRO VAL GLU GLU LEU SEQRES 21 B 316 PHE LYS LEU LEU LYS GLU GLY HIS ARG MET ASP LYS PRO SEQRES 22 B 316 ALA ASN CYS THR ASN GLU LEU TYR MET MET MET ARG ASP SEQRES 23 B 316 CYS TRP HIS ALA VAL PRO SER GLN ARG PRO THR PHE LYS SEQRES 24 B 316 GLN LEU VAL GLU ASP LEU ASP ARG ILE LEU THR LEU THR SEQRES 25 B 316 THR ASN GLU GLU HET GOL A 801 6 HET GSH A 802 35 HET WXQ A 803 51 HET GOL B 801 14 HET GOL B 802 14 HET GOL B 803 14 HET WXQ B 804 51 HETNAM GOL GLYCEROL HETNAM GSH GLUTATHIONE HETNAM WXQ N-{4-[4-AMINO-5-(4-METHOXYPHENYL)-7-METHYL-7H- HETNAM 2 WXQ PYRROLO[2,3-D]PYRIMIDIN-6-YL]PHENYL}PROP-2-ENAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 4(C3 H8 O3) FORMUL 4 GSH C10 H17 N3 O6 S FORMUL 5 WXQ 2(C23 H21 N5 O2) FORMUL 10 HOH *153(H2 O) HELIX 1 AA1 PRO A 477 ASP A 479 5 3 HELIX 2 AA2 THR A 524 GLY A 542 1 19 HELIX 3 AA3 ASN A 571 ARG A 579 1 9 HELIX 4 AA4 THR A 599 GLN A 620 1 22 HELIX 5 AA5 ALA A 628 ARG A 630 5 3 HELIX 6 AA6 ASP A 644 ALA A 648 5 5 HELIX 7 AA7 PRO A 666 MET A 670 5 5 HELIX 8 AA8 ALA A 671 ASP A 677 1 7 HELIX 9 AA9 THR A 681 THR A 698 1 18 HELIX 10 AB1 PRO A 708 GLU A 718 1 11 HELIX 11 AB2 THR A 729 TRP A 740 1 12 HELIX 12 AB3 VAL A 743 ARG A 747 5 5 HELIX 13 AB4 THR A 749 THR A 765 1 17 HELIX 14 AB5 PRO B 477 ASP B 479 5 3 HELIX 15 AB6 THR B 524 GLY B 542 1 19 HELIX 16 AB7 ASN B 571 ARG B 579 1 9 HELIX 17 AB8 THR B 599 GLN B 620 1 22 HELIX 18 AB9 ALA B 628 ARG B 630 5 3 HELIX 19 AC1 PRO B 666 ALA B 671 5 6 HELIX 20 AC2 PRO B 672 ASP B 677 1 6 HELIX 21 AC3 THR B 681 THR B 698 1 18 HELIX 22 AC4 PRO B 708 GLU B 710 5 3 HELIX 23 AC5 GLU B 711 GLU B 718 1 8 HELIX 24 AC6 THR B 729 TRP B 740 1 12 HELIX 25 AC7 VAL B 743 ARG B 747 5 5 HELIX 26 AC8 THR B 749 GLU B 767 1 19 SHEET 1 AA1 5 LEU A 481 GLU A 489 0 SHEET 2 AA1 5 GLN A 494 VAL A 501 -1 O MET A 497 N LYS A 485 SHEET 3 AA1 5 ALA A 511 MET A 518 -1 O VAL A 512 N ALA A 500 SHEET 4 AA1 5 TYR A 561 GLU A 565 -1 O VAL A 564 N ALA A 515 SHEET 5 AA1 5 LEU A 550 CYS A 554 -1 N GLY A 552 O ILE A 563 SHEET 1 AA2 2 CYS A 622 ILE A 623 0 SHEET 2 AA2 2 ARG A 649 ASP A 650 -1 O ARG A 649 N ILE A 623 SHEET 1 AA3 2 VAL A 632 VAL A 634 0 SHEET 2 AA3 2 MET A 640 ILE A 642 -1 O LYS A 641 N LEU A 633 SHEET 1 AA4 5 LEU B 481 GLY B 488 0 SHEET 2 AA4 5 GLN B 494 VAL B 501 -1 O MET B 497 N LYS B 485 SHEET 3 AA4 5 ALA B 511 MET B 518 -1 O VAL B 514 N ALA B 498 SHEET 4 AA4 5 TYR B 561 GLU B 565 -1 O VAL B 564 N ALA B 515 SHEET 5 AA4 5 LEU B 550 CYS B 554 -1 N GLY B 552 O ILE B 563 SHEET 1 AA5 2 CYS B 622 ILE B 623 0 SHEET 2 AA5 2 ARG B 649 ASP B 650 -1 O ARG B 649 N ILE B 623 SHEET 1 AA6 2 VAL B 632 VAL B 634 0 SHEET 2 AA6 2 MET B 640 ILE B 642 -1 O LYS B 641 N LEU B 633 CRYST1 105.460 117.130 64.860 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009482 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008538 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015418 0.00000